Cookie Policy - To find out more about cookies on this website, see our privacy policy

Cookie Policy

We Help Companies Find New Sales Opportunities

We Help Companies Find New Sales Opportunities

Intercytex


Intercytex has closed its operation in Cambridge, as part of a restructuring of its stem cell business which includes the sale of its Axordia subsidiary to Pfizer for £0.5m.
25-Nov-2009


Intercytex has acquired Axordia, the Sheffield-based stem cell therapies firm, for £1.7m.
23-Dec-2008


Intercytex is to raise £12m in a share placing to fund the expansion of its Cambridge-based cell therapy business.
04-May-2007